Ensaio em fase de recrutamento = ; Ensaio a decorrer = ; Ensaio concluído = ; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Bayern
MÜNCHEN

Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate replacement therapy, in patients with Pantothenate Kinase-associated Neurodegeneration (PKAN): A Randomized, Double-blind, Placebo-Controlled Study with an Open-Label Extension (Phase III) -DE-

Friedrich-Baur-Institut

Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik

Mais detalhes

Ensaio (s) clínico (s) multinacional (ais)

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate replacement therapy, in patients with Pantothenate Kinase-associated Neurodegeneration (PKAN): A Randomized, Double-blind, Placebo-Controlled Study with an Open-Label Extension

Institution: Information not provided - US

Mais detalhes